CLINICAL_TRIALS
trial_result
· 2014-02-10
Clinical Trial Update: Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 trial evaluating aripiprazole as an adjunctive therapy to antidepressants in adults with major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-10